Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hodgson, J. G.
Right arrow Articles by Hayden, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hodgson, J. G.
Right arrow Articles by Hayden, M. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 5, 1875-1885, Copyright © 1996 by Oxford University Press


ARTICLES

Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype

JG Hodgson, DJ Smith, K McCutcheon, HB Koide, K Nishiyama, MB Dinulos, ME Stevens, N Bissada, J Nasir, I Kanazawa, CM Disteche, EM Rubin and MR Hayden
Department of Medical Genetics, University of British Columbia, Vancouver, Canada.

Huntington disease (HD) is caused by expansion of a CAG trinucleotide repeat in exon 1 of a novel gene. The HD protein (huntingtin) plays a critical role in early embryonic development since homozygous targeted disruption of the murine HD gene results in embryonic lethality by day 7.5. To rescue this phenotype by transgene based huntingtin expression it is therefore essential to express the protein early enough in development in the appropriate cells. Since YAC based transgenes are known to be regulated in an appropriate temporal and tissue-specific manner, we sought to rescue the embryonic lethality by breeding YAC transgenic mice expressing human huntingtin with mice heterozygous for the targeted disruption. We generated viable offspring homozygous for the disrupted murine HD gene but expressing human huntingtin derived from the YAC. This result clearly shows that YAC transgene based expression of huntingtin occurs prior to 7.5 days gestation. Additionally, we show that human huntingtin expression in YAC transgenic mice follows an identical tissue distribution and subcellular localisation pattern as that of the murine endogenous protein and that expression levels of 2-3 times endogenous can be achieved. This shows that human huntingtin under the influence of its native promoter, despite differences to the murine protein, is functional in a murine background and can compensate for loss of the murine protein. These results show that YAC transgenic approaches are a particularly promising route to producing an animal model for disorders associated with CAG expansion.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
M. A. Pouladi, R. K. Graham, J. M. Karasinska, Y. Xie, R. D. Santos, A. Petersen, and M. R. Hayden
Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin
Brain, April 1, 2009; 132(4): 919 - 932.
[Abstract] [Full Text] [PDF]


Home page
DMMHome page
D. E. Ehrnhoefer, S. L. Butland, M. A. Pouladi, and M. R. Hayden
Mouse models of Huntington disease: variations on a theme
Dis. Model. Mech., March 1, 2009; 2(3-4): 123 - 129.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. K. Graham, M. A. Pouladi, P. Joshi, G. Lu, Y. Deng, N.-P. Wu, B. E. Figueroa, M. Metzler, V. M. Andre, E. J. Slow, et al.
Differential Susceptibility to Excitotoxic Stress in YAC128 Mouse Models of Huntington Disease between Initiation and Progression of Disease
J. Neurosci., February 18, 2009; 29(7): 2193 - 2204.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. M. Van Raamsdonk, W. T. Gibson, J. Pearson, Z. Murphy, G. Lu, B. R. Leavitt, and M. R. Hayden
Body weight is modulated by levels of full-length Huntingtin
Hum. Mol. Genet., May 1, 2006; 15(9): 1513 - 1523.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. S. Abrahams, M. C. H. Kwok, E. Trinh, S. Budaghzadeh, S. M. Hossain, and E. M. Simpson
Pathological Aggression in "Fierce" Mice Corrected by Human Nuclear Receptor 2E1
J. Neurosci., July 6, 2005; 25(27): 6263 - 6270.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. J. Slow, J. van Raamsdonk, D. Rogers, S. H. Coleman, R. K. Graham, Y. Deng, R. Oh, N. Bissada, S. M. Hossain, Y.-Z. Yang, et al.
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
Hum. Mol. Genet., July 1, 2003; 12(13): 1555 - 1567.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. M. Peier, K. L. McIlwain, A. Kenneson, S. T. Warren, R. Paylor, and D. L. Nelson
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features
Hum. Mol. Genet., May 1, 2000; 9(8): 1145 - 1159.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Tomizuka, T. Shinohara, H. Yoshida, H. Uejima, A. Ohguma, S. Tanaka, K. Sato, M. Oshimura, and I. Ishida
Double trans-chromosomic mice: Maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies
PNAS, January 18, 2000; 97(2): 722 - 727.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
A. S. Hackam, R. Singaraja, C. L. Wellington, M. Metzler, K. McCutcheon, T. Zhang, M. Kalchman, and M. R. Hayden
The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity
J. Cell Biol., June 1, 1998; 141(5): 1097 - 1105.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.